Literature DB >> 26262881

Alirocumab (Praluent) to lower LDL-Cholesterol.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26262881

Source DB:  PubMed          Journal:  Med Lett Drugs Ther        ISSN： 0025-732X            Impact factor:   1.909


× No keyword cloud information.
  1 in total

1.  Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy: Payer Approvals and Rejections, and Patient Characteristics for Successful Prescribing.

Authors:  Gregory P Hess; Pradeep Natarajan; Kamil F Faridi; Anna Fievitz; Linda Valsdottir; Robert W Yeh
Journal:  Circulation       Date:  2017-10-30       Impact factor: 29.690
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.